Nutritional Science Funding Opportunities
| Title | Announcement # |
Expiration Date |
|---|---|---|
| Nutrigenetics and Nutrigenomics Approaches for Nutrition Research | PA-18-034 (R01 Clinical Trial Optional) | 09/08/2019 |
| Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure | PAR-18-727 (R01 Clinical Trial Optional) | 09/28/2019 |
| Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) | PA-18-817 | 04/16/2020 |
| Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) | PA-18-818 | 04/16/2020 |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression ( | PA-18-739 (R21 Clinical Trial Optional) | 05/08/2021 |
| Exploratory/Developmental Clinical Research Grants in Obesity | PA-18-720 (R21 Clinical Trial Optional) | 05/08/2021 |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression | PA-18-738 (R01 Clinical Trial Optional) | 05/08/2021 |
| Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research | PA-18-876 (R01 Clinical Trial Not Allowed) | 09/08/2021 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-892 (R21 Clinical Trial Optional) | 09/08/2021 |
| Diet and Physical Activity Assessment Methodology | PA-18-856 (R01 Clinical Trial Not Allowed) | 09/08/2021 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-893 (R01 Clinical Trial Optional) | 09/08/2021 |
| Diet and Physical Activity Assessment Methodology | PAR-18-857 (R21 Clinical Trial Not Allowed) | 09/08/2021 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer | PAR-19-198 (R01 Clinical Trial Not Allowed) | 11/09/2021 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer | PAR-19-199 (R21 Clinical Trial Not Allowed) | 11/09/2021 |